Exhibitors

NEOLACT® PGLA: NEOLACT® PGLA, is a sterile, synthetic, braided and coated surgical suture material made of 90% Glycolic Acid + 10% Lactic Acid. It is dyed in FDA approved (D&C Violet No.2) to make it easily distinguishable. It is non-antigenic and nonpyrogenic. NEOLACT® PGLA has a reliable and predictable absorption profile, as well as having very high initial tensile and knot-pull strength. The braided threads are coated with PGLA 37 (30% Glycolic Acid + 70% Lactic Acid) and Calcium Stearate. NEOLACT® PGLA retains approximately 75% of its initial tensile strength on 14th day of its application and has approximately 50% of its initial tensile strength on day 21. It provides wound support for up to 28 days. In normal perfusion of tissues, NEOLACT® PGLA s absorption is essentially completed between 56-70 days. NEOLACT® RAPID PGLA: NEOLACT® RAPID PGLA, is a sterile, synthetic, braided and coated surgical suture material made of 90% Glycolic Acid + 10% Lactic Acid, degraded for quicker absorption. The thread is undyed, therefore beige in color. It is non-antigenic and non-pyrogenic. NEOLACT® RAPID PGLA has a reliable and predictable absorption profile, as well as having very high initial tensile and knot-pull strength. The braided threads are coated with PGLA 37 (30% Glycolic Acid + 70% Lactic Acid) and Calcium Stearate. NEOLACT® RAPID PGLA retains approximately 50% of its initial tensile strength on 7 day post implantation and provides effective wound support for 7 to 10 days. It loses all of its tensile strength between 10 - 14 days. In normal perfusion of tissues, NEOLACT® RAPID PGLA s absorption is completed in approximately 42 days.

NEOCRYL® PGA: NEOCRYL® PGA, is a sterile, synthetic, braided and coated surgical suture material made of 100% Polyglycolic Acid. It is dyed in FDA approved (D&C Violet No.2) to make it easily distinguishable. It is non-antigenic and non-pyrogenic. NEOCRYL® PGA has a reliable and predictable absorption profile, as well as having very high initial tensile and knotpull strength. The braided threads are coated with Calcium Stearate and Polycaprolactone. NEOCRYL® PGA retains approximately 65% of its initial tensile strength on 14th day post implantation and has approximately 35% of its initial tensile strength on day 21. It provides wound support for up to 28 days. In normal perfusion of tissues, NEOCRYL® PGA s absorption is essentially completed between 60-90 days. NEOCRYL® RAPID PGA: NEOCRYL® RAPID PGA, is a sterile, synthetic, braided and coated surgical suture material made of polymers of 100% Polyglycolic Acid, degraded for quicker absorption. The thread is undyed, therefore beige in color. It is non-antigenic and non-pyrogenic. NEOCRYL® RAPID PGA has a reliable and predictable absorption profile, as well as having very high initial tensile and knot-pull strength. The braided threads are coated with Calcium Stearate and Polycaprolactone. NEOCRYL® RAPID PGA retains approximately 50% of its initial tensile strength on 7 day post implantation and provides effective wound support for 7 to 10 days. It loses all of its tensile strength between 10 - 14 days. In normal perfusion of tissues, NEOCRYL® RAPID PGA s absorption is completed in approximately 42 days.

NEOXONE® PDS, is a sterile, synthetic and absorbable monofilament surgical suture material obtained by polymerization of the p-dioxanone monomer. It is dyed in FDA approved (D&C Violet No.2) to make it easily distinguishable. NEOXONE® PDS retains approximately 70% - 80% of its initial tensile strength on 14 day post implantation and 50% - 60% of its initial tensile strength by the 28th day. It provides effective wound support for up to 8-9 weeks. Absorption is minimal in the first 90 days and in normal perfusion of tissues, NEOXONE® PDS s absorption is completed between 180 - 210 days.

NEOPLENE® Ultra is a sterile, synthetic and monofilament non-absorbable surgical suture material made of polypropylene. It is dyed in blue or black to make it easily distinguishable. NEOPLENE® Ultra s monofilament structure, ideal tensile strength, smooth and slippery surface, minimal pack memory, extra smoothness and controlled linear elongation provides excellent knot placement and tie-down, high knot safety and perfect handling, as well as providing smooth passage through tissues with minimum resistance, thereby inflicting minimal trauma on tissues. NEOPLENE® Ultra meets all requirements of the European Pharmacopoeia (EP - Pharm. Eur.) and the United States Pharmacopoeia (USP).

NEOSILK® Ultra is a sterile, braided (twisted in 8/0 and finer sizes) and non-absorbable surgical suture material that is composed of an organic protein called fibroin, derived from 100% natural silk fibers obtained from the cocoons of silk worms by a special purification process called degumming. It is dyed in black to make it easily distinguishable and has successfully passed the dye permanence tests performed by TSE. NEOSILK® Ultra is coated with silicone (except for 8/0 and finer sizes) which provides non-capillarity and enables the suture to easily and reliably slide without damaging itself while tying knots. It also provides smooth passage through tissues with minimal resistance, thereby inflicting minimal trauma on tissues. Furthermore, NEOSILK® Ultra s ideal tensile strength, smooth and slippery surface obtained by silicone coating, minimal pack memory and extra smoothness provides excellent knot placement and tie-down, high knot safety and perfect handling. NEOSILK® Ultra meets all requirements of the European Pharmacopoeia (EP - Pharm. Eur.) and the United States Pharmacopoeia (USP).